<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN"
       "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" dtd-version="1.3" article-type="research-article" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="nlm-ta">Ulutas Med J</journal-id>
   <journal-title-group>
    <journal-title>The Ulutas Medical Journal</journal-title>
    <abbrev-journal-title>Ulutas Med J</abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="ppub">2149-0430</issn>
   <issn pub-type="epub">2149-388X</issn>
   <publisher>
    <publisher-name>Hayriye Zehra Ulutaş</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.5455/umj.20260803090348</article-id>
   <article-id pub-id-type="publisher-id">330036</article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>Original Article</subject>
    </subj-group>
    <subj-group subj-group-type="subject">
     <subject>Intensive Care Medicine</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title>Association of High Positive End-Expiratory Pressure with Intra-Abdominal Pressure and Urine Output in Critically III Patients: A Prospective Observational Study</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8218-1217</contrib-id>
     <name name-style="western">
      <surname>Yuzkat</surname>
      <given-names>Nureddin</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <aff id="aff1">
     <label>1</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/041jyzp61</institution-id>
      <institution>Department of Anesthesiology and Reanimation, Faculty of Medicine, Van Yuzuncu Yil University, Türkiye</institution>
     </institution-wrap>
    </aff>
   </contrib-group>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-09-28">
    <day>28</day>
    <month>09</month>
    <year>2026</year>
   </pub-date>
   <pub-date publication-format="print" date-type="collection">
    <year>2026</year>
   </pub-date>
   <volume>12</volume>
   <issue>3</issue>
   <fpage>41</fpage>
   <lpage>48</lpage>
   <history>
    <date date-type="received" iso-8601-date="2026-08-03">
     <day>03</day>
     <month>08</month>
     <year>2026</year>
    </date>
    <date date-type="rev-recd" iso-8601-date="2026-08-27">
     <day>27</day>
     <month>08</month>
     <year>2026</year>
    </date>
    <date date-type="accepted" iso-8601-date="2026-09-17">
     <day>17</day>
     <month>09</month>
     <year>2026</year>
    </date>
   </history>
   <permissions>
    <copyright-statement>© 2026 The Author(s)</copyright-statement>
    <copyright-year>2026</copyright-year>
    <license>
     <ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
     <license-p>This is an open access article distributed under the CC BY 4.0 licence.</license-p>
    </license>
   </permissions>
   <self-uri xlink:href="https://www.ulutasmedicaljournal.com/?mno=330036"/>
   <self-uri content-type="pdf" xlink:href="https://www.ulutasmedicaljournal.com/pdf/330036.pdf"/>
   <abstract>
    <p>Background: This study evaluated the association between high positive end-expiratory pressure (PEEP) and hourly urine output and intra-abdominal pressure (IAP) in critically ill patients receiving mechanical ventilation. Materials and Methods: This single-center, prospective observational study included 40 adult patients who were expected to require invasive mechanical ventilation for at least 24 hours. We classified patients into a low-PEEP group (4–6 cmH₂O; n=20) and a high-PEEP group (14–16 cmH₂O; n=20) based on the PEEP level prescribed as part of routine clinical care. We recorded body weight-normalized hourly urine output and measured IAP using the intravesical technique at baseline and at 12 and 24 hours. We analyzed data using two-way repeated-measures analysis of variance. Results: No significant group effect [F(1,38)=0.61; p=0.441], time effect [F(2,76)=0.22; p=0.804], or group-by-time interaction [F(2,76)=0.25; p=0.781] was observed for hourly urine output. IAP showed a significant group effect [F(1,38)=5.99; p=0.019], with an estimated marginal mean difference of 2.17 mmHg between the high- and low-PEEP groups. IAP also increased over time [F(2,76)=6.65; p=0.002]. Recurrent intra-abdominal hypertension was more frequent in the high-PEEP group than in the low-PEEP group (45% vs 10%; p=0.031). Conclusion: High PEEP was not associated with a significant reduction in hourly urine output during the 24-hour observation period; however, it was associated with higher IAP.</p>
   </abstract>
   <kwd-group kwd-group-type="author">
    <kwd>Positive-Pressure Respiration</kwd>
    <kwd>Intra-Abdominal Hypertension</kwd>
    <kwd>Urine</kwd>
    <kwd>Respiration</kwd>
    <kwd>Artificial</kwd>
    <kwd>Critical Care</kwd>
   </kwd-group>
   <funding-group>
    <funding-statement>No institution/organization provided financial support for this study.</funding-statement>
   </funding-group>
  </article-meta>
 </front>
 <body>
  <sec id="sec-1">
   <title>Introduction</title>
   <p id="b-1">Positive end-expiratory pressure (PEEP) is applied during mechanical ventilation to prevent alveolar collapse, increase functional residual capacity, and improve oxygenation (    <xref ref-type="bibr" rid="ref1">1</xref>
,    <xref ref-type="bibr" rid="ref2">2</xref>
). However, the increase in intrathoracic pressure induced by PEEP may reduce venous return and cardiac output while increasing right ventricular afterload and the systemic venous pressure. These hemodynamic alterations may adversely affect renal perfusion, glomerular filtration, and urine output (    <xref ref-type="bibr" rid="ref3">3</xref>
–    <xref ref-type="bibr" rid="ref5">5</xref>
).</p>
   <p id="b-2">The renal effects of PEEP are multifactorial. In addition to reduced cardiac output, increases in central venous and renal venous pressures may decrease the renal perfusion gradient (    <xref ref-type="bibr" rid="ref6">6</xref>
,    <xref ref-type="bibr" rid="ref7">7</xref>
). Mechanical ventilation may also affect renal function by activating the sympathetic nervous system and the renin–angiotensin–aldosterone system and by increasing antidiuretic hormone release. The magnitude of these responses may vary with intravascular volume status, lung recruitability, right ventricular function, and applied PEEP level (    <xref ref-type="bibr" rid="ref7">7</xref>
,    <xref ref-type="bibr" rid="ref8">8</xref>
).</p>
   <p id="b-3">Classical physiological studies have shown reductions in renal blood flow, glomerular filtration rate, and urine output during PEEP application (    <xref ref-type="bibr" rid="ref7">7</xref>
). More recently, increasing PEEP from 5 to 15 cmH₂O was associated with an increase in the renal resistive index (    <xref ref-type="bibr" rid="ref8">8</xref>
). Nevertheless, short-term changes in urine output may not fully reflect alterations in renal hemodynamics or kidney function. PEEP may also increase intra-abdominal pressure (IAP) by transmitting intrathoracic pressure to the abdominal compartment and caudally displacing the diaphragm. Higher PEEP levels have been associated with increased IAP in patients with acute lung injury or acute respiratory distress syndrome (    <xref ref-type="bibr" rid="ref9">9</xref>
). In contrast, changes in PEEP between 5 and 15 cmH₂O have not consistently affected IAP in stable patients without pulmonary disease (    <xref ref-type="bibr" rid="ref10">10</xref>
,    <xref ref-type="bibr" rid="ref11">11</xref>
). Discrepant findings suggest that the relationship between PEEP and IAP may depend on characteristics and thoracoabdominal compliance.</p>
   <p id="b-4">Sustained or repeated IAP≥12 mmHg is defined as intra-abdominal hypertension, whereas abdominal compartment syndrome is defined as IAP&gt;20 mmHg accompanied by new-onset organ dysfunction (    <xref ref-type="bibr" rid="ref12">12</xref>
). Intra-abdominal hypertension may increase renal venous pressure, impair renal perfusion, and contribute to oliguria and acute kidney injury (    <xref ref-type="bibr" rid="ref13">13</xref>
–    <xref ref-type="bibr" rid="ref15">15</xref>
). Evidence regarding the association between clinically prescribed high PEEP and short-term hourly urine output remains limited. This study primarily aimed to evaluate the association between high PEEP and hourly urine output in critically ill patients receiving mechanical ventilation. The secondary aims were to examine associations between high PEEP and IAP, intra-abdominal hypertension, and basic hemodynamic variables.</p>
  </sec>
  <sec id="sec-2">
   <title>Materials and Methods</title>
   <sec id="sec-3">
    <title>Study Design and Ethical Approval</title>
    <p id="b-5">This single-center, prospective observational study was conducted in the intensive care unit of a tertiary university hospital between June 1, 2018, and December 31, 2019.</p>
    <p id="b-6">The Clinical Research Ethics Committee of Van Yüzüncü Yıl University Faculty of Medicine approved the study protocol on May 9, 2018 (Decision No. 05). The study was conducted in accordance with the principles of the Declaration of Helsinki. We informed the legal representatives of all patients about the study and obtained written informed consent before enrollment.</p>
    <p id="b-7">PEEP levels were neither randomized nor modified for research purposes. The attending intensivist determined the PEEP level for each patient as part of routine clinical care, taking into account oxygenation status, ventilatory requirements, clinical tolerance, and hemodynamic condition.</p>
   </sec>
   <sec id="sec-4">
    <title>Patient Selection</title>
    <p id="b-8">Patients aged 18–80 years who were receiving invasive mechanical ventilation, were expected to require mechanical ventilation for at least 24 hours, remained within the same PEEP range throughout the observation period, had an indwelling urinary catheter, and were suitable for IAP measurement in the supine position were eligible. The exclusion criteria were a history of open abdominal, urological, gynecological, or obstetric surgery; marked intra-abdominal hypertension at baseline; renal replacement therapy; neurogenic bladder; contraindication to urinary catheterization; increased intracranial pressure; morbid obesity; clinically significant hemodynamic instability; and any change in PEEP level during the 24- hour observation period.</p>
   </sec>
   <sec id="sec-5">
    <title>Study Groups and Mechanical Ventilation</title>
    <p id="b-9">Patients receiving PEEP levels of 4–6 cmH₂O were classified as the low-PEEP group (Group L; n=20), whereas those receiving PEEP levels of 14–16 cmH₂O were classified as the high-PEEP group (Group H; n=20). The groups were formed according to the PEEP level prescribed as part of routine clinical care rather than through randomization. All patients were mechanically ventilated using the synchronized intermittent mandatory ventilation mode. PEEP was titrated according to individual oxygenation targets, carbon dioxide levels, clinical tolerance, and hemodynamic status. Patients remained within the same PEEP range throughout the observation period.</p>
   </sec>
   <sec id="sec-6">
    <title>Measurement Time Points</title>
    <p id="b-10">Measurements were performed at baseline (hour 0; T     <sub>1</sub>
), 12 hours (T     <sub>2</sub>
), and 24 hours (T     <sub>3</sub>
).</p>
   </sec>
   <sec id="sec-7">
    <title>Measurement of Urine Output</title>
    <p id="b-11">Hourly urine output was measured through an indwelling Foley urinary catheter, normalized to body weight, and recorded as mL/kg/h. The isotonic solution instilled into the bladder for IAP measurement was completely drained after each measurement and was excluded from the recorded urine volume.</p>
   </sec>
   <sec id="sec-8">
    <title>Measurement of Intra-Abdominal Pressure</title>
    <p id="b-12">Intra-abdominal pressure was measured using a closed intravesical pressure-monitoring system (AbViser® AutoValve® ABV320, Wolfe Tory Medical, Utah, USA). Under the sterile conditions, the system was connected to the indwelling Foley urinary catheter and flushed with 0.9% sodium chloride solution to remove air from the tubing. With the patient in the supine position, the pressure transducer was zeroed at the level of the pubic symphysis, as prespecified in the study protocol. Twenty milliliters of sterile 0.9% sodium chloride solution was instilled into the bladder through the closed system. After an equilibration period of at least 1 minute, the stable pressure value displayed on the monitor was recorded in mmHg at end-expiration (     <xref ref-type="bibr" rid="ref12">12</xref>
). After each measurement, the bladder was drained, and the instilled saline volume was excluded from the urine output calculation.</p>
   </sec>
   <sec id="sec-9">
    <title>Outcome Measures</title>
    <p id="b-13">The primary outcome was the comparison of body weight-normalized hourly urine output between the high- and low-PEEP groups during the 24-hour observation period. Secondary outcomes were changes in IAP between groups and across measurement time points; the frequency of measurements with IAP ≥12 mmHg; the occurrence of IAP≥12 mmHg at two or more measurement time points; changes in mean arterial pressure and heart rate; and the development of IAP&gt;20 mmHg. For the exploratory analysis, we classified IAP≥12 mmHg at two or more separate measurement time points as recurrent intra-abdominal hypertension.</p>
   </sec>
   <sec id="sec-10">
    <title>Statistical Analysis</title>
    <p id="b-14">Continuous variables are presented as mean±standard deviation, and categorical variables as number and percentage. We compared baseline continuous variables using the independent-samples t-test. We compared categorical variables using Pearson’s chi-square test or Fisher’s exact test, as appropriate. We analyzed repeated continuous measurements using a two-way analysis of variance with one repeated-measures factor. The PEEP group was the between-subject factor, and measurement time was the within-subject factor. The main effects of group and time and the group-by-time interaction were reported.</p>
    <p id="b-15">Effect sizes were expressed as partial eta squared (ηp²). Differences between estimated marginal means were reported with 95% confidence intervals (CIs). The proportions of patients with recurrent intra-abdominal hypertension were compared using Fisher’s exact test. A two-sided p&lt;0.05 was considered significant. Statistical analyses were performed using IBM SPSS Statistics for Windows, v20.</p>
   </sec>
  </sec>
  <sec id="sec-11">
   <title>Results</title>
   <sec id="sec-12">
    <title>Patient Characteristics</title>
    <p id="b-16">A total of 40 patients were included, with 20 patients in each PEEP group. No data were missing for the primary or secondary outcome variables. Group L included 13 men (65%) and seven women (35%), whereas Group H included nine men (45%) and 11 women (55%). The sex distribution did not differ between the groups (p=0.204). The groups were also comparable with respect to age, body weight, and body mass index. As expected, the mean PEEP level was higher in Group H (Table 1).</p>
   </sec>
   <sec id="sec-13">
    <title>Hourly Urine Output</title>
    <p id="b-17">Table 2 presents hourly urine output values at the 3 measurement time points. No significant group effect [F(1,38)=0.61; p=0.441; ηp²=0.016], time effect [F(2,76)=0.22; p=0.804; ηp²=0.006], or group-by-time interaction [F(2,76)=0.25; p=0.781; ηp²=0.006] was observed (Table 3). The estimated marginal mean across the three measurement time points was 1.23 mL/kg/h in Group L and 1.36 mL/kg/h in Group H. The mean difference between Group H and Group L was 0.13 mL/kg/h (95% CI, −0.20 to 0.45).</p>
    <table-wrap id="tbl-1" position="float">
     <label>Table 1</label>
     <caption>
      <title>Baseline characteristics of the study population</title>
     </caption>
     <graphic xlink:href="tbl-1.png">
      <alt-text>Table 1: Baseline characteristics of the study population</alt-text>
     </graphic>
    </table-wrap>
    <table-wrap id="tbl-2" position="float">
     <label>Table 2</label>
     <caption>
      <title>Distribution of hourly urine output and intraabdominal pressure by groups &amp; measurement time</title>
     </caption>
     <graphic xlink:href="tbl-2.png">
      <alt-text>Table 2: Distribution of hourly urine output and intraabdominal pressure by groups &amp; measurement time</alt-text>
     </graphic>
    </table-wrap>
    <table-wrap id="tbl-3" position="float">
     <label>Table 3</label>
     <caption>
      <title>Results of the Two-Way Repeated-Measures analysis of variance</title>
     </caption>
     <graphic xlink:href="tbl-3.png">
      <alt-text>Table 3: Results of the Two-Way Repeated-Measures analysis of variance</alt-text>
     </graphic>
    </table-wrap>
   </sec>
   <sec id="sec-14">
    <title>Intra-Abdominal Pressure</title>
    <p id="b-18">Table 2 presents intra-abdominal pressure values at the three measurement time points. A significant group effect was observed [F(1,38)= 5.99; p=0.019; ηp²=0.136]. The estimated mean difference across the measurement time points was 2.17 mmHg, with higher values in Group H (95% CI, 0.37–3.96). We also observed a significant time effect [F(2,76)=6.65; p=0.002; ηp²=0.149]. The group-by-time interaction was not significant [F(2,76)=1.46; p=0.240; ηp²=0.037], indicating that IAP increased overall during the observation period, but the pattern of change did not differ significantly between groups.</p>
   </sec>
   <sec id="sec-15">
    <title>Intra-Abdominal Hypertension</title>
    <p id="b-19">At baseline, IAP≥12 mmHg was observed in two patients (10%) in Group L and four patients (20%) in Group H. At 12 hours, the frequencies were two patients (10%) and seven patients (35%), respectively; at 24 hours, they were six (30%) and 11 patients (55%), respectively. In the exploratory analysis, recurrent intra-abdominal hypertension, defined as IAP ≥12 mmHg at two or more measurement time points, was identified in two patients (10%) in Group L and nine patients (45%) in Group H. The between-group difference was significant (Fisher’s exact test, p=0.031). The unadjusted risk ratio was 4.50. The highest recorded IAP was 17 mmHg, and no patient developed IAP&gt;20 mmHg.</p>
   </sec>
   <sec id="sec-16">
    <title>Hemodynamic Variables</title>
    <p id="b-20">No significant group effect, time effect, or group-by-time interaction was observed for mean arterial pressure. Although heart rate was generally lower in Group H, the pattern of change over time did not differ significantly between the groups. Because the groups were not randomized, patient diagnoses were heterogeneous, and illness-severity scores were unavailable, we did not interpret the between-group difference in heart rate as a direct effect of PEEP.</p>
   </sec>
  </sec>
  <sec id="sec-17">
   <title>Discussion</title>
   <p id="b-21">The principal finding was that PEEP levels of 14–16 cmH₂O were not associated with a significant reduction in hourly urine output during the 24-hour observation period. In contrast, IAP was significantly higher in patients receiving high PEEP, and recurrent intra-abdominal hypertension occurred more frequently in this group.</p>
   <p id="b-22">The absence of a significant difference in urine output should not be interpreted as evidence that high PEEP had no effect on kidney function. We evaluated urine output at only three time points, and we did not assess serum creatinine, blood urea nitrogen, glomerular filtration, renal Doppler parameters, electrolyte excretion, or acute kidney injury criteria. Furthermore, the 95% CI for the between-group difference ranged from −0.20 to 0.45 mL/kg/h and did not exclude small effects in either direction.</p>
   <p id="b-23">PEEP may affect renal function through hemodynamic/neurohormonal mechanisms. Increased intrathoracic pressure may reduce venous return and cardiac output, whereas elevated central venous and renal venous pressures may decrease the renal perfusion gradient. Activation of the sympathetic nervous system, renin–angiotensin–aldosterone system, and antidiuretic hormone secretion may also contribute to sodium and water retention (    <xref ref-type="bibr" rid="ref6">6</xref>
,    <xref ref-type="bibr" rid="ref7">7</xref>
). Annat et al. (    <xref ref-type="bibr" rid="ref7">7</xref>
) reported reductions of approximately 34% in urine output, 32% in renal blood flow, and 19% in glomerular filtration rate during PEEP application. However, that study was a short-term physiological intervention in which different ventilatory conditions were evaluated within the same patients. In the present study, we determined PEEP according to clinical requirements, and groups were not randomized. Consequently, confounding by indication and the possibility that patients in Group H had more severe respiratory failure cannot be excluded.</p>
   <p id="b-24">Fogagnolo et al. (    <xref ref-type="bibr" rid="ref8">8</xref>
) found that increasing PEEP from 5 to 15 cmH₂O increased the renal resistive index from 0.62 to 0.66 and increased the proportion of patients with an abnormal renal resistive index from 18% to 41%. These findings suggest that PEEP may affect renal vascular resistance or venous congestion without immediately reducing urine output. Chraibi et al. (    <xref ref-type="bibr" rid="ref16">16</xref>
) reported increased urine output in 77.5% of patients within 48 hours after PEEP reduction, with a mean increase of approximately 0.46 mL/kg/h. Their findings are not directly comparable with ours because their study included patients with acute respiratory distress syndrome and impaired baseline urine output, used a within-patient design, and assessed cumulative 24-hour urine output. The present study compared two independents and diagnostically heterogeneous groups and evaluated separate hourly urine output.</p>
   <p id="b-25">An important secondary finding was the significantly higher IAP in Group H. The estimated marginal mean difference of 2.17 mmHg was consistent with Verzilli et al. (    <xref ref-type="bibr" rid="ref9">9</xref>
), who reported an approximately 2–3 mmHg increase in IAP at higher PEEP. Conversely, Harnisch et al. (    <xref ref-type="bibr" rid="ref10">10</xref>
) found that increasing PEEP from 5 to 15 cmH₂O did not significantly affect IAP or splanchnic perfusion markers in stable neurosurgical patients without pulmonary disease. Differences in pulmonary disease, fluid status, thoracoabdominal compliance, and illness severity may account for these discrepant findings.</p>
   <p id="b-26">In an exploratory analysis, recurrent intra-abdominal hypertension occurred more frequently in Group H than in Group L (45% vs 10%). This finding should be interpreted cautiously because the analysis was based on a small number of patients and only three IAP measurement time points. Nevertheless, the observation is consistent with the higher overall IAP values observed in patients receiving high PEEP. Increased renal venous and interstitial pressures may impair renal perfusion even when systemic arterial pressure is maintained. In IAH-WK study, intra-abdominal hypertension was independently associated with a composite outcome of kidney injury, kidney replacement therapy, or death (    <xref ref-type="bibr" rid="ref13">13</xref>
). Multicenter and serial-measurement studies showed associations between intraabdominal hypertension, adverse renal outcomes, and mortality (    <xref ref-type="bibr" rid="ref14">14</xref>
,    <xref ref-type="bibr" rid="ref17">17</xref>
–    <xref ref-type="bibr" rid="ref19">19</xref>
).</p>
   <p id="b-27">Several factors may explain why hourly urine output remained preserved despite the higher IAP in Group H. Most IAP values were in the mild-to-moderate range, mean arterial pressure was comparable between groups, and fluid and inotropic treatments were adjusted to individual clinical needs. Mild alterations in renal perfusion may also be insufficient to produce detectable short-term changes in hourly urine output.</p>
   <p id="b-28">The strengths of the present study include normalizing urine output to body weight, repeated IAP measurements using a closed intravesical system, complete outcome data, and maintaining patients within the same PEEP range throughout the observation period. This study has several limitations. First, the groups were not randomized, resulting in a substantial risk of confounding by indication. Second, we did not record renal biomarkers, renal Doppler findings, acute kidney injury stage, fluid balance, diuretic exposure, or the need for renal replacement therapy. Third, illness-severity scores, PaO₂/FiO₂ ratio, tidal volume, plateau pressure, driving pressure, total PEEP, and intrinsic PEEP were unavailable. Fourth, the diagnostic heterogeneity of the study population may have independently affected urine output and IAP. Finally, the single-center design and small sample size limit the generalizability and precision of the findings. In addition, patients with clinically hemodynamic instability and those requiring a change in PEEP during the 24-hour observation period were excluded. These criteria may have selected a relatively more stable population and may have reduced the ability to detect renal or hemodynamic consequences associated with higher PEEP. They also limit the generalizability of the findings to patients with rapidly changing ventilatory or circulatory requirements.</p>
  </sec>
  <sec id="sec-18">
   <title>Conclusion</title>
   <p id="b-29">Compared with PEEP levels of 4–6 cmH₂O, PEEP levels of 14–16 cmH₂O were not associated with a significant reduction in hourly urine output during the 24-hour observation period. However, high PEEP was associated with higher IAP and a greater frequency of recurrent intra-abdominal hypertension. Preserved hourly urine output during high- PEEP ventilation should not be interpreted as evidence that renal hemodynamics or kidney function remain unaffected. These findings suggest that attention to intra-abdominal pressure and renal function may be warranted in patients requiring higher PEEP, particularly when additional risk factors for intra-abdominal hypertension are present. Larger prospective studies incorporating serial renal biomarkers, cumulative fluid balance, diuretic exposure, and renal Doppler measurements are required. Ethical Approval: The study protocol was approved by the Clinical Research Ethics Committee of University Faculty of Medicine on May 9, 2018 (Decision No. 05).</p>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="ref1">
    <label>1</label>
    <mixed-citation publication-type="journal">Edginton S, Kruger N, Stelfox HT et al. Methods for determining optimal positive end-expiratory pressure in patients undergoing invasive mechanical ventilation: a scoping review. Can J Anaesth 2024;71(11):1535-55.</mixed-citation>
   </ref>
   <ref id="ref2">
    <label>2</label>
    <mixed-citation publication-type="journal">Battaglini D, Roca O, Ferrer R. Positive end-expiratory pressure optimization in ARDS: physiological evidence, bedside methods and clinical applications. Intensive Care Med 2024;50(5):762-5.</mixed-citation>
   </ref>
   <ref id="ref3">
    <label>3</label>
    <mixed-citation publication-type="journal">Lambermont BC, Detry O, D’Orio V et al. Effects of PEEP on systemic venous capacitance. Arch Physiol Biochem 1997;105(4):373-8.</mixed-citation>
   </ref>
   <ref id="ref4">
    <label>4</label>
    <mixed-citation publication-type="journal">Algera AG, Pisani L, Chaves RCF et al. Effects of PEEP on lung injury, pulmonary function, systemic circulation and mortality in animals with uninjured lungs—a systematic review. Ann Transl Med 2018;6(2):25.</mixed-citation>
   </ref>
   <ref id="ref5">
    <label>5</label>
    <mixed-citation publication-type="journal">Hemmer M, Suter PM. Treatment of cardiac and renal effects of PEEP with dopamine in patients with acute respiratory failure. Anesthesiology 1979;50(5):399-403.</mixed-citation>
   </ref>
   <ref id="ref6">
    <label>6</label>
    <mixed-citation publication-type="journal">Benites MH, Suarez-Sipmann F, Kattan E, Cruces P, Retamal J. Ventilation-induced acute kidney injury in acute respiratory failure: do PEEP levels matter? Crit Care 2025;29(1):130.</mixed-citation>
   </ref>
   <ref id="ref7">
    <label>7</label>
    <mixed-citation publication-type="journal">Annat G, Viale JP, Bui Xuan B et al. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins and urinary ADH, and prostaglandins. Anesthesiology 1983;58(2):136-41.</mixed-citation>
   </ref>
   <ref id="ref8">
    <label>8</label>
    <mixed-citation publication-type="journal">Fogagnolo A, Grasso S, Morelli E et al. Impact of positive end-expiratory pressure on renal resistive index in mechanical ventilated patients. J Clin Monit Comput 2024;38(5):1145-53.</mixed-citation>
   </ref>
   <ref id="ref9">
    <label>9</label>
    <mixed-citation publication-type="journal">Verzilli D, Constantin JM, Sebbane M et al. Positive end-expiratory pressure affects the value of intra-abdominal pressure in acute lung injury/acute respiratory distress syndrome patients: a pilot study. Crit Care 2010;14(4):R137.</mixed-citation>
   </ref>
   <ref id="ref10">
    <label>10</label>
    <mixed-citation publication-type="journal">Harnisch LO, Tampe D, Wieditz J, Moerer O. Effect of positive end-expiratory pressure levels on splanchnic perfusion and intra-abdominal pressure: a prospective clinical-experimental study in lung-healthy patients. J Anesth Analg Crit Care 2026;6(1):75.</mixed-citation>
   </ref>
   <ref id="ref11">
    <label>11</label>
    <mixed-citation publication-type="journal">Dumanlıdağ US, Yüzkat N, Soyalp C, Gülhas N. Effects of increasing positive end-expiratory pressure values on intraabdominal pressure and hemodynamics: a prospective clinical study. East J Med 2019;24(2):235-41.</mixed-citation>
   </ref>
   <ref id="ref12">
    <label>12</label>
    <mixed-citation publication-type="journal">Kirkpatrick AW, Roberts DJ, De Waele J et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 2013;39(7):1190-206. 48 4-</mixed-citation>
   </ref>
   <ref id="ref13">
    <label>13</label>
    <mixed-citation publication-type="journal">Suphatheerawatr N, Jaturapisanukul S, Prommool S, Kurathong S, Pongsittisak W. Intra-abdominal hypertension among medical septic patients associated with worsening kidney outcomes: the IAH-WK study. Medicine (Baltimore) 2023;102(4):e32807.</mixed-citation>
   </ref>
   <ref id="ref14">
    <label>14</label>
    <mixed-citation publication-type="journal">Sarı Öztürk A, Konur K, Kara E. Association of serial intra-abdominal pressure measurements with renal outcomes and mortality in critically ill adults. J Clin Med 2026;15(14):5742.</mixed-citation>
   </ref>
   <ref id="ref15">
    <label>15</label>
    <mixed-citation publication-type="journal">Rocha NN, Samary CS, Antunes MA et al. The impact of fluid status and decremental PEEP strategy on cardiac function and lung and kidney damage in mild-moderate experimental acute respiratory distress syndrome. Respir Res 2021;22(1):214.</mixed-citation>
   </ref>
   <ref id="ref16">
    <label>16</label>
    <mixed-citation publication-type="journal">Chraibi H, De Longeaux K, L’her E. Diuresis increase after positive end-expiratory pressure weaning during acute respiratory distress syndrome. Sci Rep 2025;15:35272.</mixed-citation>
   </ref>
   <ref id="ref17">
    <label>17</label>
    <mixed-citation publication-type="journal">Reintam Blaser A, Regli A, De Keulenaer B et al. Incidence, risk factors, and outcomes of intra-abdominal hypertension in critically ill patients: a prospective multicenter study. Crit Care Med 2019;47(4):535-42.</mixed-citation>
   </ref>
   <ref id="ref18">
    <label>18</label>
    <mixed-citation publication-type="journal">Sugrue M, Jones F, Deane SA, Bishop G, Bauman A, Hillman K. Intra-abdominal hypertension is an independent cause of postoperative renal impairment. Arch Surg 1999;134(10):1082-85.</mixed-citation>
   </ref>
   <ref id="ref19">
    <label>19</label>
    <mixed-citation publication-type="journal">Malbrain MLNG, Chiumello D, Cesana BM et al. A systematic review and individual patient data meta-analysis on intra-abdominal hypertension in critically ill patients: the WAKE-Up project. Minerva Anestesiol 2014;80(3):293-306.</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
